Conventus Polymers Re‑engages In‑Person Partnerships Amid Rising COVID‑19 Vaccines

After 12 months of disruption, Conventus Polymers is easing back into traditional business practices. The New Jersey‑based distributor and formulator is renowned for its high‑performance plastic offerings, including a robust high‑temperature lineup featuring PEEK, PPA, PPS, PPSU, PES, and PSU. The company also specializes in creating custom thermoplastic blends that incorporate carbon fiber, long glass fiber, and other reinforcing additives.

Leveraging its agility, Conventus is rolling out a post‑pandemic strategy that prioritizes collaboration and application‑driven development through in‑person engagement. President Alexander Fung notes, “The pandemic imposed significant limits on travel and face‑to‑face interactions with suppliers and customers. With the rollout of COVID‑19 vaccines, we are intentionally re‑establishing normal business operations.”

The shift to in‑person activities materialized during a spring mold‑and‑material trial. Key stakeholders—injector Soundview Plastics, Conventus application development engineer Paul Zema, tool builder John Carpenter of F&M Tool, and the OEM designer—converged to refine product performance.

Over the past year, Conventus has expanded its workforce, adding seasoned experts in application development and materials science across North America and Greater China. The company remains true to its Latin‑derived name, “Conventus,” which means “to convene” or “to assemble,” underscoring its commitment to collaboration.

As the plastics sector navigated the pandemic, Conventus, like its peers, relied heavily on digital communication—email, text, video conferencing, and chat platforms—to stay connected. Zema emphasizes, “While digital tools are indispensable, they can’t fully capture the nuance of a face‑to‑face conversation. Sales is a contact sport, and the strongest relationships are forged in person.”